Lethality of Plasmodium falciparum (Pf) caused malaria results from 'cytoadherence', which is effected by exported Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) family. Several exported Pf proteins (exportome) including chaperones alongside cholesterol rich microdomains are crucial for PfEMP1 translocation to infected erythrocyte surface. An exported Hsp40 (heat shock protein 40) 'PFA0660w' functions as a co-chaperone of 'PfHsp70-x', and these co-localize to specialized intracellular mobile structures termed Jdots. Our studies attempt to understand the function of PFA0660w-PfHsp70-x chaperone pair using recombinant proteins. Biochemical assays reveal that N and C-terminal domains of PFA0660w and PfHsp70-x respectively are critical for their activity. We show the novel direct interaction of PfHsp70-x with the cytoplasmic tail of PfEMP1, and binding of PFA0660w with cholesterol. PFA0660w operates both as a chaperone and lipid binding molecule via its separate substrate and cholesterol binding sites. PfHsp70-x binds cholesterol linked PFA0660w and PfEMP1 simultaneously in vitro to form a complex. Collectively, our results and the past literature support the hypothesis that PFA0660w-PfHsp70-x chaperone pair assists PfEMP1 transport across the host erythrocyte through cholesterol containing 'Jdots'. Since PFA0660w seems essential for parasite survival, characterization of its interaction with PfHsp70-x and J-dots may form the basis for development of future antimalarials.
Introduction
P. falciparum is the major cause of severe complicated malaria that is responsible for ~0.4 million deaths annually 1 . This high mortality rate results from the ability of iRBCs to bind host endothelial receptors by the process of cytoadherence, which is largely due to the PfEMP1 family of proteins 2, 3 . PfEMP1 is one of the several exported protein families of Pf that play a crucial role in host erythrocyte remodelling to facilitate virulence, growth and survival of the parasites 4 . Most exported proteins carry a PEXEL (Plasmodium export element) motif 5 , while a few are exported in the absence of this signal 6 . Post infection, the parasite establishes its own protein trafficking machinery including sub-cellular organelles like Maurer's clefts (MCs) 7 etc. to facilitate protein export. PfEMP1 export has been linked to several proteins like PfSBP1, MAHRP, PfEMP3 [8] [9] [10] and various chaperones 11 that support transport of this major virulence antigen across the parasite confines.
Inside the cellular environment, chaperones prevent aggregation or misfolding of nascent polypeptides, hence accomplishing the conformational integrity of the entire proteome. The Pf genome encodes numerous chaperones including members of heat shock proteins of ~40kDa, ~ 60kDa, ~70kDa and ~90kDa families that are upregulated in response to stress caused by parasite infection [12] [13] [14] [15] [16] . Amongst all chaperones, Hsp40 members are an abundant class distributed into four types (I to IV) 17 . These members of the 'malaria exportome' 5 play crucial roles in cellular processes like protein translation, folding, translocation, and degradation 17 , underscoring their importance in parasite biology. Hsp40s are molecular co-chaperones of Hsp70s, and contain a highly conserved J-domain 18 . They target protein substrates to Hsp70s for folding, and stabilize them in the substrate bound form [19] [20] [21] . The J domain exhibits four helices and a highly conserved His-Pro-Asp (HPD) tripeptide motif that is vital for stimulating the ATPase activity of Hsp70 22, 23 . Hsp70 proteins consist of two distinct functional domains viz. a 45 kDa N-terminal ATPase domain, and a 25 kDa C-terminal substrate binding domain (SBD). The SBD acts as lid and facilitates entrapment of the substrate 24, 25 .
MCs have been long considered as intermediary compartments for PfEMP1 export 26, 27 . More recently, Kulzer et al., reported cholesterol containing novel mobile structures termed 'J-dots' to be involved in trafficking of parasite encoded proteins (e.g. PfEMP1) across the host cytosol 28 . Furthermore, delivery of this key protein is reported to involve its insertion at cholesterol rich membrane microdomains 29 . Chaperone complexes from other species have also been shown to associate with detergent resistant lipid rafts rich in cholesterol and sphingolipids, possibly through Hsp70 30, 31 . J dots are known to carry exported PfHsp40 chaperones (PFA0660w, PFE0055c) and PfHsp70-x present as large complexes with several other exported proteins 28, 32, 33 . PFA0660w, a type II PEXEL positive PfHsp40 has been reported to be essential for survival of parasites inside erythrocytes 5 .
Immunofluorescence assays revealed partial co-localization of these GFP-tagged PfHsp40s and PfHsp70-x with PfEMP1, suggesting a role for these chaperones in PfEMP1 transport 30, 31 . This was supported by another report where deletion of PfHsp70-x led to delayed export of PfEMP1 to the erythrocyte surface 34 . Another study elucidated the trafficking of PfHsp70x and demonstrated that its export takes place via the PTEX translocon and is directed by an N-terminal secretory signal sequence 35 . Though the role of PfHsp70-x and cholesterol has been implicated in export of the PfEMP1 family of proteins through in vivo experiments, the underlying mechanism of this process remains ambiguous.
In the present study, we provide the first direct evidence for the molecular interplay of events in this crucial process using recombinant proteins and their lipid interactions. We have performed domain characterization of the PFA0660w-PfHsp70-x chaperone pair that sheds light on how these partners interact with each other to execute their function. We also depict binding of PfHsp70-x with 'PfEMP1', and display cholesterol binding properties of PFA0660w. Our results show that cholesterol and substrate binding sites on PFA0660w exist in distinct pockets on the protein, highlighting its dual functionality. Our complex binding assays clearly illustrate that PfHsp70-x interacts together with both cholesterol-linked PFA0660w and PfEMP1 to form a complex. Together, our results provide mechanistic insights into the functional role of the PFA0660w-PfHsp70-x chaperone pair. These studies hence serve to fill the key knowledge gaps in the understanding of Pf biology and are very likely to form the framework for structure-based drug design against fatal malaria.
Results

Cloning, expression and purification of recombinant proteins
PFA0660w displays a Sis1/Hdj1 domain organization containing a J domain (encompassing the Hsp70 interaction site at the N-terminus) followed by a G/F motif rich region and a substrate binding domain ( Fig. 1A , top left panel). Residues 'RCLAE' (58) (59) (60) (61) (62) represent the PEXEL motif responsible for the export of this protein to the host cell ( Fig.1B ).
PfHsp70-x possesses two domains viz. an N-terminal nucleotide-binding domain (NBD) with
ATPase activity, which is connected by a linker region to a SBD present in the C-terminal region ( Recombinant Hsp40 and Hsp70 proteins were purified using Ni-NTA affinity and gel permeation chromatographies, while acidic terminal segment (ATS) domain of PfEMP1 was purified as reported earlier 36, 37 . Purified PfHsp70-x-S, PfHsp70-x-C, PFA0660w-C, PFA0660w-S and ATS run as species of approximately 45 kDa, 70 kDa, 38 kDa, 28 kDa and 45 kDa respectively on SDS-PAGE ( Fig. 1C ). Bands below the expected molecular weight can be observed particularly for PfHsp70-x-S, PfHsp70-x-C and ATS (Fig. 1C ) owing to protein degradation. This is evident from western blots of recombinant proteins probed with anti-hexahistidine monoclonal antibodies (ATS 36 , Fig. S1A for Hsp40 and Hsp70 constructs).
Polyclonal antisera were raised against PFA0660w-S commercially in rabbits, and specificity validated by testing on a crude extract of E. coli BL21 (DE3) transformed with its cloned plasmid ( Fig. S1B ).
Recombinant PFA0660w and PfHsp70-x exist as monomers in solution
Dimeric Hsp40s alongwith monomeric Hsp70s have been reported to perform chaperone activity in the past 38, 39 . However, elution profiles of PFA0660w-C and PfHsp70x-C on gel filtration column suggested that both these recombinant proteins exist as monomers (~ 38kDa and 70kDa respectively) in solution ( Fig. 2A ). Elution volumes of standards (BSA, chymotrypsin and lysozyme) were used for comparison to deduce the oligomeric state of these proteins (Fig. S2 ).
We have used in silico tools to structurally understand the reason for existence of PFA0660w in a monomeric form. Structures of human DnaJ subfamily B member 12 (PDB ID: 2CTP, 54% identity) and dimerization domain of Cryptosporidium parvum Hsp40 (PDB ID: 2Q2G, 49% identity) were used as templates for modelling J domain (78-154) and Cterminal region (226-398) of PFA0660w respectively using Swiss model tool, and refined using 3D refine ( Fig. 2B ). Various tests like Ramachandran plot, Verify 3D and Errat were run on the generated models to assess their acceptability, and were found suitable for structural analysis (Fig. S3 ).
Atomic resolution structures of C-terminal peptide-binding fragments of type II
Hsp40s from S. cerevisiae (Sis1, PDB ID: 1C3G) and C. parvum (PDB ID: 2Q2G) revealed that both exist as homo-dimers 38, 40 . The Protein interaction calculator (PIC) computed several hydrophobic interactions and hydrogen bonds to be involved in dimerization of these proteins (Table S1 ). Although most of these interactions were found conserved in our modelled structure, a few hydrophobic interactions were found absent from the dimer interface. Specifically, V250 (helix II, chain A) -L325 (helix III, chain B) and A252 (helix II, chain A) -F309 (helix III, chain B) hydrophobic bonds in C. parvum Hsp40 were unable to form in PFA0660w due to replacement of non-polar residues V250 and A252 with polar amino-acids E323 and S325 respectively ( Fig 2C) . Also, substitution of L281 (Sis1, chain A) with T327 in PFA0660w may lead to disruption of L281 -L340 (chain B) interaction ( Fig.   2C ).
Additionally, Sha et al. have reported several residues from crystal structure of yeast Hsp40 'Sis1' to form its dimer interface 38 . These include F276, K277, L280, Y336, L340, I348 and D349 where K277 (helix II, A chain) -D349 (helix III, B chain) form a salt bridge, while F276, L280, Y336, L340 and I348 stabilise the dimer formation 38 . Multiple sequence alignment of different type II Hsp40s showed most of these residues to be semi-conserved ( Fig. S4 ).
N-terminal region of PFA0660w interacts with PfHsp70-x
Binding studies of different deletion constructs using dot blot assays showed interaction of PFA0660w-C with PfHsp70-x-C and PfHsp70-x-S, ( Inability of PFA0660w-S to bind PfHsp70-x also behaves as an internal negative control for the experiment. Anti-PFA0660w antibodies used in the assay were tested for cross-reactivity with PfHsp70-x-C; no signal was obtained in this blot (Fig. S5A ).
The binding of PFA0660w with PfHsp70-x was also studied using glutaraldehyde cross linking assay commonly used to monitor complex formation of Hsp70 with its cochaperones 41 Binding of PFA0660w-C was also studied with denatured malate dehydrogenase (MDH -a substrate for chaperones) using glutaraldehyde crosslinking assay ( Fig. 3B ). MDH alone existed as monomers, dimers and large oligomers upon crosslinking ( Fig. 3B lane 11) .
After PFA0660w-MDH crosslinking, the bands for PFA0660w-C and MDH oligomers disappeared ( Fig. 3B lane 13) , demonstrating the substrate -chaperone interaction.
PFA0660w-PfHsp70-x binding was also investigated using indirect ELISA assays which reveal significant and specific interaction of PFA0660w-C with both PfHsp70-x constructs in a concentration dependent manner that saturated at higher concentrations ( Fig.   3C ). We employed in vitro pull down assays to measure the binding strength of PFA0660w-PfHsp70-x interaction and to confirm the behaviour of PFA0660w as a co-chaperone of PfHsp70-x. PfHsp70-x-C was cross-linked to amino plus coupling resin and increasing concentrations of PFA0660w-C were added in the presence (substrate interactions abrogated) and absence of ATP (substrate interactions possible). BSA cross-linked beads incubated with PFA0660w-C were used as a negative control. Bound fractions of PFA0660w-C were eluted and separated on SDS PAGE (Fig. 3D ), and the integrated density of the bands measured.
Binding of PFA0660w-C to PfHsp70-x-C was saturable with an equilibrium dissociation constant (K d ) of 0.7814 ± 0.1504 µM and 5.576 ± 1.786 µM in the presence and absence of ATP respectively (Fig. 3E ). Enhanced binding affinity observed in the presence of ATP suggests the partners to be a chaperone/co-chaperone pair.
In silico structural assessment of modelled PFA0660w revealed that its J domain consists of four α helices with the HPD motif residing in the loop region between helices II and III (Fig. 2B ). The overall fold of the predicted structure matched that of E. coli DnaJ (Hsp40 homolog) (1XBL, 1BQZ, 1BQ0) and human Hdj1 (1HDJ). As reported earlier, the HPD signature motif drives Hsp40-70 binding 23, 42 while lysine and arginine residues (KR) of the QKRAA motif present in helix IV of the J domain of E. coli DnaJ play a crucial role in interaction with DnaK (Hsp70 homolog) 18 . Multiple sequence alignment of various type II Hsp40 family members recognizes both the HPD motif and 'KR' of QKRAA motif to be conserved amongst Plasmodium and non-Plasmodium species (Fig. S4 ). Besides, both these are surface exposed on PFA0660w (Fig. 2B ), and hence likely to comprise the binding residues in PfHsp40-PfHsp70 interactions.
Chaperone activity assays
Thermolabile protein substrates have been extensively used to study the chaperone activity of heat shock proteins 43, 44 . Previous studies by Daniyan et al. reported additive effect of PFA0660w and PfHsp70-x in suppressing aggregation of the substrate 'rhodanese' 45 .
Here, we have employed a set of assays using MDH and beta galactosidase as model substrates for assessing the holdase and foldase functions of recombinant PFA0660w and PfHsp70-x. The holdase function was characterized by quantifying the ability of different combinations of PFA0660w and PfHsp70-x deletion constructs to suppress MDH aggregation ( Fig. 4a ). The foldase function was investigated by measuring enzymatic activity of beta galactosidase renatured using recombinant Hsps (Fig. 4b ).
MDH aggregation was monitored spectrophotometrically at 360nm, and considered 100% at saturation (>20minutes) in the absence of any chaperone. PFA0660w-C alone suppressed MDH aggregation efficiently (48.35% aggregation), and was even more effective when added with PfHsp70-x-C (10.71% aggregation) (p<0.05) ( Fig. 4a ). However, reduction in MDH aggregation using PFA0660w-C and PfHsp70-x-S partnership was relatively less (18.17% aggregation). Interestingly, PFA0660w-S alone or in combination with PfHsp70-x-C or PfHsp70-x-S was unable to suppress MDH aggregation (p>0.05). These data provide evidence that PFA0660w-C having the complete conserved region is able to act as a chaperone independently and can functionally interact with both constructs of PfHsp70-x to reduce MDH aggregation more efficiently, whereas PFA0660w-S is non-functional. Also, PfHsp70-x-C alone reduced MDH aggregation better (21.83% aggregation) than PfHsp70-x-S (88.82% aggregation) (p<0.05) ( Fig. 4a ), emphasizing the importance of its C-terminal region containing the 'EEVN' motif in regulating its chaperone activity. In the absence of MDH, each of the recombinant protein used in the study was found to be thermally stable as none of them aggregated under the assay conditions (Data not shown). BSA was used as a negative control in the experiment to ensure specificity of MDH aggregation suppression by these chaperones.
Beta galactosidase recognizes ONPG as its substrate and cleaves it into orthonitrophenol (ONP) and galactose. Absorbance at 420nm measures the amount of ONP produced in the reaction which is a reflection of the ability of chaperones to refold denatured beta galactosidase. In these experiments, the activity of beta galactosidase without denaturation was considered as 100%. BSA itself (negative control) was unable to refold beta galactosidase post denaturation. The activity of denatured beta galactosidase was partially recovered by addition of PFA0660w-C (22.6%), PfHsp70-x-C (43.1%) and PfHsp70-x-S (9.8%) (p < 0.05) but not with PFA0660w-S (p > 0.05) ( Fig. 4b ). Therefore, PfHsp70-x-C was found to be most efficient in refolding its substrate. Enzymatic activity was significantly increased (66.66%) when PFA0660w-C and PfHsp70-x-C were added together, validating their interaction and suggesting co-ordinated activity (p < 0.05). PFA0660w-C-PfHsp70-x-S partnership was also more effective in refolding action (34.7%, p < 0.05) as compared with PFA0660w-C alone. However, no significant effect was observed when PFA0660w-S-PfHsp70-x-C or PFA0660w-S-PfHsp70-x-S pairs were used in the assay (p > 0.05) ( Fig. 4b ).
BSA-PfHsp70-x-C pair enzyme refolding activity matched that of PfHsp70-x-C alone, verifying the accuracy of the assay (p > 0.05). 
Both chaperone activity assays provide evidence for functionality of recombinant
PfHsp70-x interacts with ATS domain of PfEMP1
Since PFA0660w and PfHsp70-x co-localize with PfEMP1 in J-dots 28, 32 , we tested binding of PFA0660w and PfHsp70-x with ATS (acidic terminal segment) domain of PfEMP1 using in vitro assays. Preliminary screening was performed using dot blot assays where recombinant PFA0660w-C, PFA0660w-S, PfHsp70-x-C and PfHsp70-x-S were immobilized on nitrocellulose (NC) membrane and allowed to bind with PfEMP1 before probing with ATS specific antisera ( Fig. 5A ). Both deletion constructs of PfHsp70-x showed significant binding with PfEMP1, whereas no interaction was observed for constructs of PFA0660w ( Fig. 5A ). Integrated density of each dot further demonstrates significant binding of PfHsp70-x-C and PfHsp70-x-S with ATS domain of PfEMP1 (p<0.05) ( Fig. 5A ). Absence of signal with immobilized BSA (negative control) demonstrates the specificity of the assay.
Anti-ATS antibodies used in the assay were tested for cross-reactivity with recombinant PFA0660w-C and PfHsp70-x-C; no signal was obtained ( Fig. S5B ). Our semi-quantitative ELISA assays also depict significant binding of PfHsp70-x with ATS domain in a concentration dependent manner in contrast to deletion constructs of PFA0660w (Fig. 5B ).
Binding of PfHsp70-x-C and PfHsp70-S with PfEMP1 showed saturation at higher concentrations ( Fig. 5B ). In vitro pull down assays followed by western blot analysis also 
C-terminus of PFA0660w binds cholesterol
J-dots are likely membranous structures with unclear lipid composition, and are reported to carry PfHsp40s 28 . Several chaperones have been reported to localize to specific sub-cellular regions, possibly through binding with lipids 30, 46 . Therefore, we investigated association of chaperone pair 'PFA0660w-PfHsp70-x' with common membrane lipids (phosphatidylcholine and cholesterol) using lipid-protein overlay assays 47 . Binding to a closely related sterol, 'ergosterol' and triglycerides were also tested in the assay. Lipids were spotted on NC membrane and incubated with PFA0660w-C, PFA0660w-S, PfHsp70-x-C and PfHsp70-x-S before probing with monoclonal anti-hexahistidine antibodies (Fig. 6A ). Our results clearly show the ability of PFA0660w-C and PFA0660w-S to bind specifically with cholesterol but not with other lipids ( Binding saturation was achieved at higher concentrations of PFA0660w-C and PFA0660w-S.
Phosphatidylcholine, ergosterol and triglyceride failed to bind either chaperone, defining assay specificity ( Fig. 6B ). To measure the binding strength of cholesterol with recombinant PFA0660w-C, we used an assay in which the protein was immobilized on Ni-NTA resin before addition of increasing concentrations of cholesterol ( Fig. 6C ). Bound cholesterol was quantified by Zak's method 48 , where binding of cholesterol to PFA0660w-C was saturable with a K d value of 4.82 ± 1.3µM ( Fig. 6C ). PfHsp70-x-C showed no binding with cholesterol in this experiment. We also performed BLI to study the kinetics of PFA0660w-C-cholesterol interaction. Fig. 6D (left panel) shows association and disassociation phases of the curves obtained for cholesterol binding to immobilized PFA0660w-C. A K d value of 13 ± (7x10 -15 ) µM was generated from the steady state analysis which was obtained by plotting response at equilibrium as a function of analyte concentrations ( Fig. 6D ; right panel).
PFA0660w-S hosts separate binding sites for cholesterol and substrate (MDH)
C-terminal region of PFA0660w carries both substrate and cholesterol binding sites.
We analyzed the surface representation of modelled C-terminal PFA0660w to understand where cholesterol is likely to bind on this protein, and found two major hydrophobic grooves ( Fig. 7A) . One constituted the substrate binding pocket 38 , while the second was present on the extreme C-terminal end of this domain (Fig. 7A) . The latter is reported to form the dimer interface in Hsp40 homologs from other species 38, 39 . Therefore, we investigated whether denatured MDH and cholesterol bind to separate sites or compete for binding to PFA0660w-S. PFA0660w-S bound Ni-NTA beads were saturated with denatured MDH before incubation with increasing concentrations of cholesterol to test whether this causes displacement of bound MDH. SDS-PAGE analysis of bound fractions shows no effect of cholesterol addition on MDH band intensity, suggesting existence of distinct cholesterol and substrate binding pockets on PFA0660w-S (Fig. 7B, upper panel) . Absence of leaching of PFA0660w-S bound MDH in unbound fractions upon cholesterol addition validates these findings (Fig.7A, lower panel). Direct binding of denatured MDH non-specifically to Ni-NTA beads was experimentally ruled out (Fig. 7B, lane 7, upper panel) . Densitometric analyses of band intensities of PFA0660w-S and MDH observed on SDS-PAGE was performed to quantify the result (Fig. 7B, right panel) .
PfHsp70-x binds PFA0660w and PfEMP1 simultaneously in-vitro to form a complex
Since PfHsp70-x binds both PFA0660w and ATS of PfEMP1, we tested its potential to attach with both proteins simultaneously to form a complex using in-vitro aminoplus coupling resin based pull down assays 36 . Recombinant PfHsp70-x-C was coupled to the resin, and allowed to bind PFA0660w-C, followed by ATS. Elutes from the assay were analysed by western blot analysis using specific polyclonal antisera against PFA0660w and ATS simultaneously. Distinct bands of ATS and PFA0660w-C eluted from PfHsp70-x-C cross linked beads were observed ( Fig 7C, lane 1) , while no band was detected where beads were crosslinked with PFA0660w-C and incubated with ATS (lane 2). Cross linked PfHsp70-
x-C incubated with ATS and PFA0660w-C separately showed PfHsp70-x-C ̶ ATS and To test association of this complex with lipids, we performed lipid-protein overlay assays. Cholesterol and phosphatidylcholine were immobilized on NC membrane and allowed to bind PFA0660w-C, PfHsp70-x-C and ATS sequentially. The blot was probed with specific polyclonal antisera against ATS. A strong signal was detected for Cholesterol-PFA0660w-C-PfHsp70-x-C-ATS, but none for immobilized phosphatidylcholine (Fig. 7D ).
PfHsp70-x-C ̶ ATS and PfHsp70x-C ̶ PFA0660w-C (positive controls) and BSA (negative control) were included in the assay.
Discussion
Parasite encoded exported chaperones are involved in the cellular refurbishment of infected human erythrocytes, and play an important role in the establishment of protein folding pathways in the host cell. Understanding the molecular interplay of Pf heat shock proteins provide functional insights into malaria biology. In this study, we have explored various aspects of PFA0660w-PfHsp70-x interaction, and attempted to delineate its function in infected red blood cells.
Two deletion constructs each of PFA0660w and PfHsp70-x were cloned in pET-28a(+) vector and overexpressed in soluble form in a bacterial expression system [BL21 (DE3) E. coli cells]. A recent study reported expression of recombinant hexahistidine-tagged PFA0660w in the insoluble fraction when cloned in pQE30 vector 45 . Biochemical characterization and atomic resolution three dimensional structures of Hsp40s from other organisms (yeast Sis1, human Hdj1) reveal these to exist as dimers 38, 39 . Deletion of Sis1 dimerization unit affects its ability to function as a chaperone 38 . Here, the cleft formed between the two monomers helps in holding the substrate peptide and deliver it to Hsp70 38, 39 .
C-terminal regions of both C. parvum Hsp40 (cgd2_1800) 40 and E. coli DnaJ play a role in their dimerization, and the latter is reported to be necessary for its chaperone function 49 . In contrast to these studies, we found PFA0660w to exist as a monomer when investigated by gel permeation chromatography and glutaraldehyde crosslinking assays ( Fig. 2A, 3B ). Our results corroborate those of Daniyan et al., who had previously reported refolded PFA0660w to attain monomeric conformation in solution 45 . Lack of PFA0660w dimer formation is also consistent with a recent report on the characterization of a novel Type III Hsp40, 'Tbj1' from Trypanosoma brucei 50 . Our in silico analysis using multiple sequence alignment and dimer interface residue mapping on homology models predicts the role of hydrophobic interactions in homo-dimerization of Hsp40s. Since oligomeric state of Hsp40 proteins is directly linked to their function, we emphasize that PFA0660w is structurally and functionally different from its counterparts in other organisms, including humans. Such striking structural differences between host and parasite protein counterparts identify essential 'PFA0660w' as a candidate for structure-based drug design against Pf caused malaria.
Our binding studies reveal that the PFA0660w-PfHsp70-x interaction is mediated by the N-terminus of PFA0660w containing its J domain and the G/F region (Fig. 3) , which may serve to provide specificity to this molecular interaction. Independent ability of PfHsp70-x-S to bind with PFA0660w-C recognises the importance of the ATPase domain on PfHsp70-x in forming the major binding site.
Daniyan et al. have previously reported functionality of recombinantly expressed
PFA0660w and PfHsp70-x, and an additive effect in chaperone activity when used together 45 . Interrogating the role of different domains in chaperone action is vital for understanding the functional partnership of the PFA0660w -PfHsp70-x pair. Our chaperone activity assays using various deletion constructs reveal that conserved length construct PFA0660w-C could function alone, and showed cooperative action with both constructs of PfHsp70-x ( Fig. 4) .
However, PFA0660w-S (C-terminal region) was inactive in either assay, highlighting the functional significance of its N-terminus. These results are coherent with previous literature where Hsp40 proteins have been shown to exhibit intrinsic chaperone activity besides acting as co-chaperones 44, 51 . Similarly, significant difference in the capability of PfHsp70-x-S and PfHsp70-x-C to perform their chaperone activity identifies the importance of its C-terminal region carrying the 'EEVN' motif in regulating its chaperone function. 'EEVD', a regulatory motif found in eukaryotic Hsp70s at the extreme carboxyl terminal has been reported to effect its ATPase activity and binding to both its partner 'Hsp40' and substrates 52 . Collectively, our domain analysis identifies N-terminus of PFA0660w and C-terminus of PfHsp70-x as critical for functionality of this chaperone pair.
PfHsp70-x deletion from parasites leads to delayed export of PfEMP1 to iRBC surface 34 . Both PFA0660w and PfHsp70-x have been observed to localize to specialized mobile structures in the erythrocyte cytosol, termed 'J-dots' 28, 32 . These are different from the well characterized Maurer's clefts and are believed to be formulated with a distinct lipid composition 28 . Also, cholesterol rich microdomains have been implicated in the trafficking of major cytoadherence ligand 'PfEMP1' 29 . In light of the above facts, we tested binding of PFA0660w and PfHsp70-x with ATS domain of PfEMP1, and identified in vitro interaction of PfHsp70-x with ATS ( Fig. 5 ). PfHsp70-x-S showed similar binding as the conserved length protein, suggesting its N-terminal region to contain the binding site for ATS. This is the first report of direct binding of PfHsp70-x with ATS domain of PfEMP1, which adds another piece in solving the jigsaw puzzle of PfEMP1 trafficking.
Kulzer et al. had indicated tight association of PFA0660w-GFP with J-dots, possibly
by protein-cholesterol interaction 28 . However, in vivo trials to understand PFA0660wcholesterol interaction in J-dots did not provide conclusive evidence, probably owing to cholesterol concentrations below detectable limits of the method used. Therefore, we tested direct binding of PFA0660w and PfHsp70-x with cholesterol and other common membrane lipids. Our data demonstrate specific interaction of PFA0660w with cholesterol, while
PfHsp70-x did not show any lipid binding properties (Fig. 6 ). PFA0660w-S having only its C-terminal region also showed similar cholesterol binding pattern, suggestive of a role for its carboxyl terminus in anchorage to J-dots. Recently, a report on targeting of GFP tagged PFE0055c (another J-dot resident Hsp40 protein) to infected erythrocytes showed that its SBD fused with a signal peptide and PEXEL motif on the N-terminus is necessary and sufficient for recruiting the protein to J-dots 53 . Since C-terminal region of PFA0660w shares 54% identity with PFE0055c, we hypothesize the role of its SBD in targeting PFA0660w to J-dots by a direct cholesterol dependent interaction. We further propose that PfHsp70-x may be recruited to J-dots through its specific interaction with PFA0660w, though involvement of other molecular players is not ruled out.
We marked the hydrophobic residues on modelled C-terminal PFA0660w (Residues 226-398) to identify a probable binding site for cholesterol on this protein. In silico analysis of its surface representation revealed the presence of an additional far C-terminal major hydrophobic groove apart from its substrate binding pocket. This region is ordinarily involved in homo-dimer formation in Hsp40 counterparts from other species 38, 39 .
Considering the monomeric state of PFA0660w, it is likely that this additional pocket may form its cholesterol binding site (Fig. 7A ). Our in vitro Ni-NTA based assays revealed presence of distinct binding sites for denatured MDH (substrate) and cholesterol on Cterminus of PFA0660w (Fig. 7B) . This highlights the ability of PFA0660w to dually function as a chaperone and membrane linking molecule simultaneously.
Since PfHsp70-x binds both PFA0660w and ATS of PfEMP1, we tested whether both recombinant proteins bind PfHsp70-x together to form a complex, or compete with each other for attachment to PfHsp70-x. Our assays clearly show that PfHsp70-x binds both PFA0660w and PfEMP1 simultaneously in vitro suggestive of separate binding sites for these on PfHsp70-x ( Fig. 7C ). Proteome analysis coupled with biochemical studies revealed PfHsp70x to exist in different high molecular weight complexes at J-dots, and the parasitophorous vacuole (PV) 33 . Though co-immunoprecipitation experiments failed to detect PfEMP1 in these complexes probably due to experimental limitations, presence of PfEMP1 here is still very likely 33 . Our in vitro studies also suggest that PfEMP1 may associate with PfHsp70-x and Hsp40 containing complexes. Further, our dot blot assay shows that PFA0660w-PfHsp70-x-PfEMP1 complex is able to link itself to cholesterol via PFA0660w (Fig. 7D ).
Our results are in line with previous studies by Frankland et al. who demonstrated the role of cholesterol rich structures in export of PfEMP1 to the surface of infected erythrocytes 29 . It is interesting to speculate here that cholesterol depletion may interrupt linkage of PFA0660w-PfHsp70-x-PfEMP1 complex to J-dots, and prevent subsequent delivery of PfEMP1 to iRBC membrane. There also exists evidence for formation of large chaperone containing soluble complexes of PfEMP1 to mediate its trafficking across the host cytosol 11, 54 . From our studies and previous data, we hypothesise a model for the role of PFA0660w-PfHsp70-x chaperone pair in PfEMP1 transport via direct association with cholesterol containing J-dots ( Fig. 8) .
Our model is supported by the observation of all three members of the complex in J-dots 28, 32 .
We propose formation of this complex either pre or post exit from PV to erythrocyte cytosol through the translocon. Since PfHsp70-x has been dually localized to both PV and J-dots 32 , it is probable that PEXEL negative PfHsp70-x delivers cargo (e.g. PfEMP1) to the erythrocyte cytoplasm with the assistance of PEXEL positive proteins like PFA0660w. A recent report has detailed the association of PfHsp70-x with PTEX on the trans side of the PVM 33 . After crossing the parasite confines, the said complex may insert into the J-dots before being delivered to the iRBC surface either via Maurer's clefts or directly to the knobs.
Emerging resistance to the currently available drugs against malaria is a major threat to mankind, and demands development of newer agents to combat this disease 55, 56 .
Understanding molecular interactions of essential Pf proteins may provide the key to identification of new inhibitors through structure-based drug design. Since PFA0660w is essential for parasite survival and is significantly different from its host counterpart, drugs that target its molecular networking with PfHsp70-x or cholesterol are likely to impact malaria pathogenesis and parasite survival. Recombinant ATS domain of PF08_0141 was purified for experiments as previously described 36, 37 .
Material and methods
Cloning, expression and purification of recombinant proteins
Structure prediction and validation
Blastp against the RCSB Protein Databank (PDB) was used to find suitable templates for modelling the J domain and C-terminal region of PFA0660w 57 . Models were generated using Swiss Model tool 58 and were refined by 3D refine, a protein structure refinement server 59 . The refined models were evaluated using VERIFY 3D, ERRAT and RAMPAGE programs [60] [61] [62] . PyMol was used for visualization and analysis of protein structures 63 
. Protein
Interactions Calculator (PIC) server was used to identify the possible dimer interface residues of C. parvum Hsp40 (PDB ID: 2Q2G) and yeast Sis1 64 .
Dot blot assays
For screening protein-protein interactions of PfHsp70-x with PFA0660w, and various Hsp constructs with ATS of PfEMP1, the recombinant purified PfHsp70-x or Hsp proteins (~1µg each) were immobilized on NC membrane. Blots were blocked with 5% BSA in PBS for 2 hrs, and hybridized with ~20µg of probe protein (PFA0660w or ATS of PfEMP1 respectively) for 1 hr. After extensive washing, blots were incubated with probe protein specific antibodies (1:5000) for 1 hr followed by horseradish peroxidise (HRP)-conjugated goat anti-rabbit (for PFA0660w) or HRP conjugated goat anti-mice (for ATS) secondary antibody (1:2000) . Relevant recombinant purified Hsp proteins were used as positive controls, while BSA was used as a negative control in the assay. Integrated densities of dots were measured using ImageJ after background correction 65 .
Glutaraldehyde cross linking
Recombinant proteins (~60µg) were suspended in crosslinking buffer (50mM sodium phosphate pH 8, 100mM NaCl in the presence or absence of ATP and MgCl 2 (2mM each)) in a total volume of 100l, and incubated at 37ºC for 15 minutes. l of 2.3% glutaraldehyde was added to the reaction and incubated at 37ºC for another 30 minutes. MDH was denatured at 48ºC prior to crosslinking with PFA0660w-C. The reaction was terminated by adding 10µl of stop solution (1 M Tris-HCl, pH 8.0), and samples were resolved on 12% SDS-PAGE.
Plate based interaction studies
In vitro interactions of PFA0660w with PfHsp70-x, and various Hsp constructs with ATS of PfEMP1 were examined by indirect ELISA. 100ng each of purified bait proteins (recombinant purified PfHsp70-x or Hsp proteins) were coated on ELISA plates and blocked with 5% BSA in PBS overnight at 4 o C. The coated ligands were incubated with increasing concentrations of prey proteins (PFA0660w or ATS of PfEMP1 respectively; range: 10ng to 500 ng) for 2 hrs at room temperature, followed by extensive washing with 1X PBS. Washed plates were incubated with anti-PFA0660w-S (1:5000) or anti-ATS antibodies (1:5000) followed by anti-rabbit or anti-mice HRP conjugated secondary antibodies (1:10,000) for two hrs. Plates were developed using 1mg/ml OPD (o-phenylenediamine dihydrochloride) containing H 2 O 2 , and absorbance measured at 490nm.
For investigating protein-lipid interaction, a similar protocol as described above was followed where 100ng of lipids were coated on ELISA plates and allowed to bind with varying concentration of hexahistidine tagged recombinant proteins (PFA0660w-C, PFA0660w-S, PfHsp70-x-C and PfHsp70-x-S). Bound proteins were detected by incubating plates with monoclonal anti-hexahistidine-HRP conjugated antibodies (1:10,000).
Protein pull down assay
Pierce chemical co-immunoprecipitation kit was used according to the manufacturer's protocol to evaluate direct protein-protein interaction of PfHsp70-x (bait protein) with either PFA0660w or ATS of PfEMP1 (prey). Briefly, 10µl of coupling resin was cross-linked with 20µg PfHsp70-x-C for 2 hrs. After extensive washing, protein coupled resin was incubated with increasing concentrations of PFA0660w-C (1.4286, 2.871, 7.1429, 14.287, 28.5714 µM)
in the presence and absence of 1mM ATP or 50 µg of ATS respectively diluted in 200 μl of binding buffer. Unbound protein was removed by repeated washing with binding buffer, followed by elution of prey protein. As a negative control, BSA was coupled to the resin as bait before incubation with PFA0660w-C or ATS. Samples of bound PFA0660w-C were resolved on 12% SDS-PAGE and band intensities measured using ImageJ after background correction. K d was determined by fitting the curve with nonlinear regression using GraphPad Prism 7.0 software (GraphPad Software, CA, USA). Eluted samples incubated with ATS were subjected to western blot analysis using anti-ATS antibodies.
Malate dehydrogenase (MDH) aggregation suppression assays
MDH aggeregation suppression assays were carried out as previously reported 44 . for 10 minutes followed by termination with 300l of 1M Na 2 CO 3 as stop solution. BSA was used in place of recombinant proteins as a negative control. Absorbance was recorded at 420nm for each reaction.
Beta galactosidase refolding assays
Biolayer interferometry assays
Protein-protein and protein-lipid interaction studies were carried out using Forte Bio Octet K2 instrument at 25°C in solid black 96-well plates. The binding assay kinetics were 
Lipid protein overlay assays
Nitrocellulose membranes were soaked in TBS buffer before 0.5µg of methanol suspended lipids were spotted and allowed to dry for 1 hr at room temperature. Membrane was blocked with 5 % BSA in TBS for 2 hrs followed by incubation with 25µg of hexahistidine tagged proteins (PFA0660w-C, PFA0660w-S, PfHsp70-x-C and PfHsp70-x-S).
Membranes were washed with 0.05% TBST followed by TBS and incubated with monoclonal anti-hexahistidine-HRP conjugated antibodies (1:2000) for 2 hrs, and developed.
This assay was also employed to test complex formation ability of cholesterol-PFA0660w-C-PfHsp70-x-C-ATS. A similar protocol as described above was followed except that after immobilization of lipids, the membrane was hybridized with PFA0660w-C followed by PfHsp70-x-C and then ATS (1 hr each). Blots were incubated with anti-ATS antibodies (1:5000) for 1 hr followed by HRP-conjugated goat anti-mice secondary antibody (1:2000) , and developed.
Cholesterol Binding assay
100µg of recombinant protein was allowed to bind with Ni-NTA resin followed by blocking with 5% BSA in TBS. After washing, increasing concentration of cholesterol (10-400 µM in binding buffer (50mM Tris, pH 7.4, 150mM NaCl, 0.004% NP-40)) was allowed to bind with protein immobilized resin for 4 hrs. Resin was washed with binding buffer, and cholesterol bound protein was eluted with elution buffer (binding buffer + 250mM imidazole). Concentration of bound cholesterol was estimated by Zak's method 48 using a standard curve for cholesterol. Concentration of free cholesterol was calculated by subtracting bound concentration from total cholesterol added in the assay. K d was determined by fitting a hyperbola directly to the saturation isotherm using GraphPad Prism 7.0 software (GraphPad Software, CA, USA).
Bead based cholesterol/MDH binding assay
Ni-NTA resin bound to PFA0660w-S was used to test whether MDH and cholesterol bind this Hsp40 together to form a complex, or compete for binding. 20µg of purified recombinant PFA0660w-S was allowed to bind with Ni-NTA beads followed by blocking with 5% BSA in TBS. Bound PFA0660w-S was saturated with a standardized fixed concentration of denatured MDH (200µg) for 2 hrs with intermittent mixing; MDH was incubated at 48ºC for denaturation prior to binding. After extensive washing with TBS, increasing concentrations of cholesterol (50, 100, 150, 200, 300µM) 
Complex binding assay
In-vitro formation of a complex between PFA0660w, PfHsp70-x and ATS was tested using Pierce co-immunoprecipitation kit. 25µg of PfHsp70-x-C was coupled to the beads, and blocked with 5% BSA overnight at 4 o C. Coupled resin was incubated with recombinant PFA0660w-C (2 hrs) followed by ATS for 2 hrs. PfHsp70-x-C was cross linked and incubated with ATS and PFA0660w-C separately as positive controls. PFA0660w-C and PfSBP-1 were coupled to beads separately and incubated with ATS and PFA0660w-C respectively as negative controls. Eluted samples were subjected to western blot analysis to probe for PFA066w-C and ATS by anti-PFA066w-C and anti-ATS antibodies respectively on the same blot.
Statistical analysis
Statistical significance was analysed by one way ANOVA (Tuckey's post hoc test) using SPSS version 16 66 . Values with P value < 0.05 were considered as statistically significant. was measured by its ability to convert substrate ONPG to yellow colored ONP whose absorbance was recorded at 420 nm. Experiments were performed in triplicates; error bars represent the standard deviation. '*', '#', '@', '$' represent statistically significant difference at p<0.05 relative to BSA, PFA0660w-C, PfHsp70-x-C and PfHsp70-x-S respectively. 
Figure legends
